Cargando…
COX-2 as a potential biomarker and therapeutic target in melanoma
With a constantly increasing incidence, cutaneous melanoma has raised the need for a better understanding of its complex microenvironment that may further guide therapeutic options. Melanoma is a model tumor in immuno-oncology. Inflammation represents an important hallmark of cancer capable of induc...
Autores principales: | Tudor, Diana Valentina, Bâldea, Ioana, Lupu, Mihai, Kacso, Teodor, Kutasi, Eniko, Hopârtean, Andreea, Stretea, Roland, Gabriela Filip, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142851/ https://www.ncbi.nlm.nih.gov/pubmed/32296574 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0339 |
Ejemplares similares
-
Celecoxib as a Valuable Adjuvant in Cutaneous Melanoma Treated with Trametinib
por: Tudor, Diana Valentina, et al.
Publicado: (2021) -
Low Doses of Celecoxib Might Promote Phenotype Switching in Cutaneous Melanoma Treated with Dabrafenib—Preliminary Study
por: Tudor, Diana Valentina, et al.
Publicado: (2022) -
Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers – a comparative study
por: BALDEA, IOANA, et al.
Publicado: (2015) -
Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy
por: Tudor, Diana, et al.
Publicado: (2017) -
Goji-Berry-Mediated Green Synthesis of Gold Nanoparticles and Their Promising Effect on Reducing Oxidative Stress and Inflammation in Experimental Hyperglycemia
por: David, Luminita, et al.
Publicado: (2023)